Syngoi
Producer of synthetic deoxyribonucleic acid intended to address the needs of advanced therapies. The company is engaged in the production of synthetic DNA through a new enzymatic process that addresse...
Valuation
$0
Share Price
N/A
Total Raised
$0
Last Round
N/A